Owners
Vertiflex is the Californian company which makes low-invasive devices for treatment of patients with a moderate degenerative stenosis of lumbar department of a backbone. The system of an indirect decompression Vertiflex Superion creates additional spaces between awned shoots of vertebras, reducing pressure upon nerves and relieving pain. The procedure is intended for patients who do not answer the oral anesthetizing medicines or injections of steroids, but symptoms of which are insufficiently serious to justify such heavy transactions as spondilodez or a laminektomiya.
History
2019: Boston Scientific purchased Vertiflex for $465 million
At the beginning of June, 2019 the producer of the medical equipment Boston Scientific announced acquisition of Vertiflex for $465 million. At achievement of certain commercial criteria within the next three years additional payments from the buyer are possible.
The Vertiflex company received the registration certificate on the Superion system in 2015. The device is intended for elderly patients with a stenosis of lumbar department of a backbone – a common cause of pains in a waist, especially at people 60 years are more senior. This status is caused by gradual narrowing of the vertebral channel which squeezes the nerves passing in it that leads to development of pain and spasms.
The efficiency of the Superion device is confirmed by data of a two-year research among 400 patients, at least 80% from which announced reduction of pain in legs and improvement of the shared physical state. In 5 years after treatment among the patients using Superion, the use of opioids decreased by 85%.
The Superion system will become the next addition of neuromodulation department of Boston Scientific which already makes the systems of deep stimulation of a brain, stimulators of a spinal cord and the radio-frequency systems of ablation. Boston Scientific expects that sales of the Vertiflex Superion device in 2019 will make $60 million[1]